These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22530874)

  • 1. The impact of macular edema on visual function in intermediate, posterior, and panuveitis.
    Taylor SR; Lightman SL; Sugar EA; Jaffe GJ; Freeman WR; Altaweel MM; Kozak I; Holbrook JT; Jabs DA; Kempen JH
    Ocul Immunol Inflamm; 2012 Jun; 20(3):171-81. PubMed ID: 22530874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
    ; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
    Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial.
    Mackensen F; Jakob E; Springer C; Dobner BC; Wiehler U; Weimer P; Rohrschneider K; Fiehn C; Max R; Storch-Hagenlocher B; Becker MD
    Am J Ophthalmol; 2013 Sep; 156(3):478-486.e1. PubMed ID: 23786783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular edema in uveitis.
    Mitkova-Hristova VT; Konareva-Kostianeva MI
    Folia Med (Plovdiv); 2012; 54(3):14-21. PubMed ID: 23270202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.
    Kempen JH; Sugar EA; Jaffe GJ; Acharya NR; Dunn JP; Elner SG; Lightman SL; Thorne JE; Vitale AT; Altaweel MM;
    Ophthalmology; 2013 Sep; 120(9):1852-9. PubMed ID: 23706700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.
    Levin MH; Pistilli M; Daniel E; Gangaputra SS; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Kempen JH;
    Ophthalmology; 2014 Feb; 121(2):588-95.e1. PubMed ID: 24332536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of inflammatory cystoid macular edema.
    Tranos PG; Tsaousis KT; Vakalis AN; Asteriades S; Pavesio CE
    Retina; 2012 Sep; 32(8):1624-8. PubMed ID: 22481481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual acuity and microperimetric mapping of lesion area in eyes with inflammatory cystoid macular oedema.
    Munk MR; Kiss CG; Huf W; Montuoro A; Sulzbacher F; Kroh M; Larsen M; Schmidt-Erfurth U
    Acta Ophthalmol; 2014 Jun; 92(4):332-8. PubMed ID: 23802743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.
    Simonazzi B; Balaskas K; Guex-Crosier Y
    BMC Ophthalmol; 2016 May; 16(1):59. PubMed ID: 27188332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
    Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
    Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.
    ; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Sugar EA
    Am J Ophthalmol; 2010 Apr; 149(4):550-561.e10. PubMed ID: 20097325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors.
    Miserocchi E; Modorati G; Di Matteo F; Galli L; Rama P; Bandello F
    Eur J Ophthalmol; 2011; 21(6):802-10. PubMed ID: 21374555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
    Kempen JH; Van Natta ML; Altaweel MM; Dunn JP; Jabs DA; Lightman SL; Thorne JE; Holbrook JT;
    Am J Ophthalmol; 2015 Dec; 160(6):1133-1141.e9. PubMed ID: 26386159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Macular Edema in Uveitis as Diagnosed by Optical Coherence Tomography in Tertiary Eye Center.
    Gupta S; Shah DN; Joshi SN; Aryal M; Puri LR
    Nepal J Ophthalmol; 2018 Jan; 10(19):39-46. PubMed ID: 31056575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.
    Whitcup SM; Csaky KG; Podgor MJ; Chew EY; Perry CH; Nussenblatt RB
    Ophthalmology; 1996 Jul; 103(7):1054-62; discussion 1062-3. PubMed ID: 8684794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optical coherence tomography in the diagnosis and follow-up of patients with uveitic macular edema].
    Reinthal EK; Völker M; Freudenthaler N; Grüb M; Zierhut M; Schlote T
    Ophthalmologe; 2004 Dec; 101(12):1181-8. PubMed ID: 15156343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
    Brar M; Yuson R; Kozak I; Mojana F; Cheng L; Bartsch DU; Oster SF; Freeman WR
    Retina; 2010 Mar; 30(3):383-9. PubMed ID: 20216291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.
    Sugar EA; Jabs DA; Altaweel MM; Lightman S; Acharya N; Vitale AT; Thorne JE;
    Am J Ophthalmol; 2011 Dec; 152(6):1044-1052.e5. PubMed ID: 21861971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.